Translational pharmacokinetic (PK), pharmacodynamic (PD) modeling and simulation analysis of MetMAb

被引：1
|
作者：
Bender, B. [1 ]
Xiang, H. [2 ]
Reyes, A. E., II [2 ]
Damico, L. A. [2 ]
Merchant, M. [3 ]
Peterson, A. [4 ]
Forrest, W. [5 ]
Jumbe, N. L. [1 ]
机构：
[1] Genentech Inc, Clin PKIPD, San Francisco, CA USA
[2] Genentech Inc, Early Dev PKIPD, San Francisco, CA USA
[3] Genentech Inc, Translat BioOncol, San Francisco, CA USA
[4] Genentech Inc, Clin BioOncol, San Francisco, CA USA
[5] Genentech Inc, NonClin Biostat, San Francisco, CA USA
来源：
EJC SUPPLEMENTS | 2008年 / 6卷 / 12期
关键词：
D O I：
10.1016/S1359-6349(08)72473-X
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：170 / 170
页数：1
相关论文
共 50 条
  • [1] Supporting MetMAb entry into the clinic with nonclinical pharmacokinetic (PK) and pharmacodynamic (PD) information
    Xiang, H.
    Reyes, A.
    Merchant, M.
    Bender, B.
    Jumbe, N.
    Young, J.
    Gelzleichter, T.
    Vaidyanathan, A.
    Peterson, A.
    Damico, L.
    EJC SUPPLEMENTS, 2008, 6 (12): : 167 - 167
  • [2] COMBINED PHARMACOKINETIC PHARMACODYNAMIC (PK/PD) MODELING
    COLBURN, WA
    JOURNAL OF CLINICAL PHARMACOLOGY, 1988, 28 (09): : 769 - 771
  • [3] Mechanism-based pharmacokinetic-pharmacodynamic (PK-PD) modeling in translational drug research
    Danhof, Meindert
    de Lange, Elizabeth C. M.
    Della Pasqua, Oscar E.
    Ploeger, Bart A.
    Voskuyl, Rob A.
    TRENDS IN PHARMACOLOGICAL SCIENCES, 2008, 29 (04) : 186 - 191
  • [4] Modeling of pharmacokinetic/pharmacodynamic (PK/PD) relationships: Concepts and perspectives
    Derendorf, H
    Meibohm, B
    PHARMACEUTICAL RESEARCH, 1999, 16 (02) : 176 - 185
  • [5] Modeling of Pharmacokinetic/Pharmacodynamic (PK/PD) Relationships: Concepts and Perspectives
    Hartmut Derendorf
    Bernd Meibohm
    Pharmaceutical Research, 1999, 16 : 176 - 185
  • [6] Pharmacokinetic/pharmacodynamic (PK/PD) modeling of captopril in healthy volunteers.
    Yi, SY
    Bae, KS
    Lim, HS
    Cho, JY
    Yu, KS
    Jang, IJ
    Shin, SG
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2001, 69 (02) : P74 - P74
  • [7] Applications of the pharmacokinetic/pharmacodynamic (PK/PD) analysis of antimicrobial agents
    Asin-Prieto, Eduardo
    Rodriguez-Gascon, Alicia
    Isla, Arantxazu
    JOURNAL OF INFECTION AND CHEMOTHERAPY, 2015, 21 (5-6) : 319 - 329
  • [8] Pharmacokinetic/pharmacodynamic (PK/PD) modeling and simulation of moxifloxacin (MOX) for the treatment of Streptococcus pneumoniae infection.
    Liu, Q
    Rand, K
    Mueller, M
    Stass, H
    Derendorf, H
    JOURNAL OF CLINICAL PHARMACOLOGY, 2004, 44 (10): : 1199 - 1199
  • [9] Pharmacokinetic-pharmacodynamic (PK-PD) modeling and simulation of 5-fluorouracil for erythropenia in rats
    Kobuchi, Shinji
    Ito, Yukako
    Hayakawa, Taro
    Nishimura, Asako
    Shibata, Nobuhito
    Takada, Kanji
    Sakaeda, Toshiyuki
    JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS, 2014, 70 (02) : 134 - 144
  • [10] Population pharmacokinetic (PK) and pharmacodynamic (PD) modeling of etanercept using logistic regression analysis.
    Lee, H
    Kimko, HC
    Rogge, M
    Wang, D
    Nestorov, I
    Peck, CC
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2002, 71 (02) : P84 - P84
12345